The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
The UK government introduces 'innovator passports' to streamline NHS adoption of new technologies, reducing red tape and enabling faster nationwide deployment of proven innovations.
Paul Edwards, Director of Clinical Services at Dementia UK, explores what dementia actually means in the 21st century, including the all-important differences between dementia and Alzheimer’s.
This LGBT history month, Philip Baldwin speaks to me about living with an HIV-positive diagnosis, Gay rights in Russia, women with HIV, Hepatitis C stigma and iconic historical figures.
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
Professor Graham MacGregor, Chair of Action on Sugar, discusses stopping excessive sugar consumption, whilst investigating obesity and type 2 diabetes.
Chris Wakefield, Vice President, European Marketing & Product Development, at GOJO Industries-Europe Ltd explores hand hygiene and how infection prevention measures can be strengthened to help save lives.
Barbara Harpham, Chair of the UK-based Medical Technology Group, explains the role that technology can play in reducing the financial and societal burden of diabetes.
In this interview, Dr Carolyn M. Hutter, PhD, Director, Division of Genome Sciences at the National Human Genome Research Institute (NHGRI) outlines the important role of research when it comes to applying genome technologies to studying disease.
Adam Fletcher, Head of British Heart Foundation (BHF) Wales tells us exactly what the key ingredients are for improving the health of the next generation during the childhood obesity challenge.
Rachel Conant, Senior Director, Federal Affairs, Alzheimer’s Association explains how bold action by the U.S. Congress delivers victory to the millions of people living with Alzheimer's.